EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications

Janis Timsans, Antti Palomäki iD, Markku Kauppi iD

Journal of Clinical Medicine · 13.12.2024 · 13 (24) · 7616

DOI: 10.3390/jcm13247616 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.12.2024. Verfasst von Janis Timsans und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Päijät-Häme Central Hospital, Wellbeing Services County of Päijät-Häme, 15850 Lahti, Finland. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gout is the most common form of inflammatory arthritis, caused by the deposition of monosodium urate crystals in the joints due to elevated serum uric acid levels. Its prevalence and associated healthcare burden have been rising in recent decades, a trend expected to continue. It is crucial to recognize that gout and hyperuricemia are not merely causes of painful joint flares, but systemic metabolic disorders linked to a broad spectrum of comorbidities such as cardiovascular diseases, chronic kidney disease, diabetes, insulin resistance, steatotic liver disease, osteoarthritis, and respiratory and eye diseases. Numerous risk factors for gout and hyperuricemia have been identified, with recent research uncovering further associations with other conditions. To optimize patient outcomes, gout and hyperuricemia must be addressed through a holistic approach that accounts for these risk factors while providing comprehensive management of related comorbidities affecting various organ systems. This review summarizes the current knowledge on the risk factors, comorbidities, and clinical implications of gout and hyperuricemia. Future research should focus on improving patient outcomes by tailoring treatments individually and addressing the underlying metabolic comorbidities of gout with multimodal treatment.

Schlagwörter

Stichwörter der Autor:innen

comorbiditiesgoutgouty arthritishyperuricemiametabolic hyperuricemiarenal hyperuricemia

Autor:innen und Institutionen

  • Department of Rheumatology, Päijät-Häme Central Hospital, Wellbeing Services County of Päijät-Häme, 15850 Lahti, Finland.
  • Faculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.
  • Centre for Rheumatology and Clinical Immunology, Turku University Hospital, 20521 Turku, Finland.
  • Department of Medicine, University of Turku, 20014 Turku, Finland.
  • Clinicum, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.

ORCID-Profile: Antti Palomäki, Markku Kauppi

Zitieren

APA

Timsans, J., Palomäki, A., & Kauppi, M. (2024). Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications. Journal of Clinical Medicine, 13(24), 7616. https://doi.org/10.3390/jcm13247616

Vancouver

Timsans J, Palomäki A, Kauppi M. Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications. Journal of Clinical Medicine. 2024;13(24):7616. doi:10.3390/jcm13247616

BibTeX
@article{Timsans2024,
  author = {Timsans, Janis and Palomäki, Antti and Kauppi, Markku},
  title = {Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {24},
  pages = {7616},
  doi = {10.3390/jcm13247616}
}
Kostenlos starten →